7-100888850-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001015072.4(UFSP1):āc.422T>Cā(p.Leu141Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000143 in 1,607,336 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001015072.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UFSP1 | NM_001015072.4 | c.422T>C | p.Leu141Ser | missense_variant | 1/1 | ENST00000388761.4 | NP_001015072.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UFSP1 | ENST00000388761.4 | c.422T>C | p.Leu141Ser | missense_variant | 1/1 | NM_001015072.4 | ENSP00000373413 | |||
UFSP1 | ENST00000672365.3 | c.650T>C | p.Leu217Ser | missense_variant | 1/1 | ENSP00000499910 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152150Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247396Hom.: 0 AF XY: 0.0000150 AC XY: 2AN XY: 133620
GnomAD4 exome AF: 0.00000619 AC: 9AN: 1455068Hom.: 0 Cov.: 31 AF XY: 0.00000553 AC XY: 4AN XY: 722994
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152268Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74458
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 10, 2022 | The c.422T>C (p.L141S) alteration is located in exon 1 (coding exon 1) of the UFSP1 gene. This alteration results from a T to C substitution at nucleotide position 422, causing the leucine (L) at amino acid position 141 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at